 Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators.  Manual de Medicina de Familia - Página 126de Mark A. Graber, Matthew L. Lanternier - 2002 - 968 páginasVista previa restringida - Acerca de este libro
 | Deepak L. Bhatt, M. Flather - 2004 - 507 páginas
...Infarction Collaborative Group. Lancet 2000:355:1575-81. 150 28. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342: 145-53. Errata... | |
 | Jean-Louis Vincent - 2003 - 1048 páginas
...protection. Circulation 90:2056-2069 68. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensinconverting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145-153 69. Anonymous... | |
 | Steven P. Marso - 2003 - 107 páginas
...hypertension and NIDDM. Diabetes Care 1998;21:597-603. 24. Yusuf S, Slcight P, Pogue J et al. Effeets of an angiotensin-converting-enzyme inhibitor, ramipril,...on cardiovascular events in high-risk patients. N EnglJ Med 2000;342:145-53. 25. Heart Outeomes Prevention Evaluation Study Investigators. Effeets of... | |
 | Yvon Berland, Bertrand Dussol, Henri Vacher-Coponat - 2003 - 398 páginas
...dialysis patients. Nephron 1997 ; 77 : 44-7. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000 ; 342 : 145-53. Péricardite... | |
 | Kyle Moylan, Tammy L. Lin - 2004 - 236 páginas
...(SHEP). SHEP Cooperative Research Group. JAMA 1991;265:3255-3264. 6. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145153. 7. Staessen... | |
 | Christopher O'Connor, Wendy Gattis Stough, Miahai Gheorghiade, Kirkwood F. Adams - 2005 - 644 páginas
...septal defect. Semin Thorac Cardiovasc Surg 1995; 7: 208-213. 48. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145-153. 49.... | |
 | Clive Rosendorff - 2007 - 888 páginas
...randomised placebo-controlled trial. Lancet 2003;361:2005-2016. 25. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-153. 26. Heart... | |
 | Michael Marmot, M. G. Marmot, Paul Elliott - 2005 - 956 páginas
...theory. Diabetic Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R. and Dagenais, G. (2000). Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. New England Journal of Medicine 342,... | |
 | Institute of Medicine, Roundtable on Evidence-Based Medicine - 2007 - 374 páginas
...Institute Monographs (35):3-1 1. Yusuf, S, P Sleight, J Pogue, J Bosch, R Davies, and G Dagenais. 2000. Effects of an angiotensinconverting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. New England Journal of Medicine 342(3):145-153.... | |
 | Charles M. Thiebauld, Pierre Sprumont - 2005 - 314 páginas
...syndrome gene. Science 272 : 258-262 YUSUF S, SLEIGHT P, POGUE J, BOSCH J, DAVIES R, DAGENAIS G 2000. Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl)Med342 : 145-153 ZACCARIA M, VARNIER... | |
| |
